Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 15Fallopian Tube Neoplasms 13Lung Neoplasms 11Melanoma 8Glioblastoma 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Urinary Bladder Neoplasms 6Triple Negative Breast Neoplasms 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Breast Neoplasms 4Brain Neoplasms 4Prostatic Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Uveal Melanoma 2Thyroid Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Rectal Neoplasms 2Oligodendroglioma 2Multiple Myeloma 2Medulloblastoma 2Lymphoma 2Liposarcoma 2Hematologic Neoplasms 2Gliosarcoma 2

Interventions

cediranib 3perifosine 2pembrolizumab 2pazopanib 2atezolizumab 2Sunitinib 2Specimen Handling 2Loperamide 2selinexor 1sargramostim 1romidepsin 1cabozantinib 1brostallicin 1atropine sulfate-diphenoxylate hydrochloride drug combination 1Warfarin 1Vitamin B 6 1Trabectedin 1Thyroxine 1Temozolomide 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Pyridoxine 1Promethazine 1Prochlorperazine 1Polymerase Chain Reaction 1Petrolatum 1Neoadjuvant Therapy 1Mass Spectrometry 1Lorazepam 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Alveolar Soft Part × Immunoglobulin G × Clear all
NCT03141684 2026-06-03

Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
63 enrolled 1 FDA
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡